The programme aims to enhance early detection and ensure timely, accurate breast cancer diagnosis by offering free immunohistochemistry tests, multidisciplinary care, and navigation services to 5,000 ...

A multinational healthcare company, Roche and a provider of digital integrated healthcare services, Oncopadi Technologies ...

The global polyclonal antibody market is poised for significant expansion in the coming decade, driven by increasing ...

Canadian researchers have developed an effective new technique for identifying aggressive medulloblastoma—the most common ...

A research team led by Prof. SUN Cheng from the University of Science and Technology of China (USTC) of the Chinese Academy of Sciences, along with ...

A research team led by Prof. Sun Cheng from the University of Science and Technology of China (USTC), in collaboration with ...

This process is known as higher-order conditioning and can be measured using sensory preconditioning tasks in rodents. This behavioral paradigm requires the repeated and simultaneous presentation of ...

Complementing its antibody offerings, BosterBio provides a range of ELISA kits designed for quantitative detection of ...

BostonGene, a leading provider of artificial intelligence (AI)-driven molecular and immune profiling solutions, today announces it was named a Fierce Life Sciences Innovation Awards winner by Fierce ...

A real-world study showed HER2DX guided treatment changes in approximately 48% of HER2-positive breast cancer cases.

Canadian researchers have developed an effective new technique for identifying aggressive medulloblastoma-the most common type of malignant brain ...